Browse Studies — Arctuva

Observational

An Open-Label Feasibility Trial to Assess the Efficacy of the Magnus Neuromodulation System With Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT)® Technology to Treat Memory Deficits in Older Patients With Treatment-Resistant Depression

The goal of this clinical trial is to learn whether Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT®), a type of transcranial magnetic stimulat…

Depressive Disorder, Treatment-ResistantMemory Deficits

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Find your next paid study

An Open-Label Feasibility Trial to Assess the Efficacy of the Magnus Neuromodulation System With Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT)® Technology to Treat Memory Deficits in Older Patients With Treatment-Resistant Depression

Investigations of Spatial Recognition Memory to Improve Cognitive Outcomes in Epilepsy Surgery